EKSO.NASDAQEkso Bionics Holdings, INC

4/A: Ekso Bionics Holdings Officer Corrects Previous SEC Filing Regarding 401(k) Stock Acquisition

Sentiment:

SEC Filing Amendment

📋All filings for Ekso Bionics Holdings, INC
🔒Login to Follow

Jason C. Jones, Chief Operating Officer of Ekso Bionics Holdings, files an amendment to a previous SEC Form 4 to correct the number of shares acquired through the company's 401(k) plan.

Summary

  • Jason C. Jones, the Chief Operating Officer of Ekso Bionics Holdings, filed an amended Form 4 with the SEC.
  • The amendment corrects an inaccuracy in the number of common stock shares acquired through the Issuer's 401(k) plan matching contribution on February 17, 2022.
  • The original Form 4, filed on June 15, 2023, stated an incorrect number of shares.
  • The corrected filing shows that Mr. Jones indirectly owns 4,591 shares of common stock through his 401(k) as of February 17, 2022, and 15,391 shares as of June 12, 2023.

Sentiment

Score: 5

Explanation: The document is a routine correction of a previous filing, indicating a neutral sentiment.

Industry Context

This filing is a routine correction of a previous disclosure related to employee stock ownership, and doesn't necessarily reflect broader industry trends.

Key Dates

DateDescription
02/17/2022Date of the original 401(k) plan matching contribution with the incorrect number of shares reported.
06/12/2023Date of a transaction where 10,800 shares were acquired.
06/15/2023Date of the original Form 4 filing containing the incorrect information.
04/04/2024Date of the amended filing.

Keywords

SEC Filing, Form 4, Amendment, Ekso Bionics, Jason Jones, 401(k), Stock Acquisition, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.